Drug
Elesclomol clinical trials
Also written STA-4783.
Includes 4 studies of Elesclomol sodium.
- studies test it
- 9
- open now
- 0
- in phase 3
- 1
- first study started
- 2003
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2004 (3)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 4
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 1
Synta Pharmaceuticals Corp. (8) · GOG Foundation (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses elesclomol is read from its arms, and is right about nine times in ten.
Testing it · 9
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedPhase 2GOG FoundationNCT00888615Written as Elesclomol Sodium
- STA-4783 and Paclitaxel for Treatment of Solid TumorsCompletedPhase 1Synta Pharmaceuticals Corp.NCT00088114Written as STA-4783/paclitaxel
- STA-4783/Paclitaxel or Paclitaxel Alone in MelanomaCompletedPhase 1/2Synta Pharmaceuticals Corp.NCT00084214Written as STA-4783
- Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in MelanomaTerminatedPhase 3Synta Pharmaceuticals Corp.NCT00522834Written as Elesclomol (STA-4783)
- A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate CancerCompletedPhase 1Synta Pharmaceuticals Corp.NCT00808418Written as Elesclomol Sodium
- Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid LeukemiaStatus unknownPhase 1Synta Pharmaceuticals Corp.NCT01280786Written as Elesclomol Sodium
- A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid TumorsSuspendedPhase 1Synta Pharmaceuticals Corp.NCT00827203Written as Elesclomol Sodium
- STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)CompletedPhase 1/2Synta Pharmaceuticals Corp.NCT00088088Written as STA 4783
- A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue SarcomasCompletedPhase 2Synta Pharmaceuticals Corp.NCT00087997Written as STA-4783
Codes
What other systems call elesclomol · ClinicalTrials.gg INT004945
- MeSH (NLM) C512195elesclomolOne source NLM
- UNII (FDA) 6UK191M53PELESCLOMOLConfirmed FDA, NLM, Wikidata
- Wikidata Q5359460elesclomolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75291ElesclomolOne source FDA
- DrugBank DB05719One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C512195 | elesclomol | One source NLM |
| UNII (FDA) | 6UK191M53P | ELESCLOMOL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5359460 | elesclomol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75291 | Elesclomol | One source FDA |
| DrugBank | DB05719 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.